Bayer Aktiengesellschaft (SWX:BAYN)

Market Cap	44.16B +71.5%
Revenue (ttm)	41.89B -1.7%
Net Income	-1.60B
EPS	-1.63
Shares Out	n/a
PE Ratio	n/a
Forward PE	10.32
Dividend	0.10 (0.22%)
Ex-Dividend Date	Apr 27, 2026

Volume	11
Open	45.57
Previous Close	45.85
Day's Range	45.57 - 45.57
52-Week Range	32.75 - 48.69
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 4, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and ge...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1863
• Employees: 87,830
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: BAYN

Financial Performance

In 2025, Bayer Aktiengesellschaft's revenue was 45.58 billion, a decrease of -2.21% compared to the previous year's 46.61 billion. Losses were -3.62 billion, 41.8% more than in 2024.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 24, 2026

Data Sources Report a data error